Daniel Granderson[email protected]Business InsightsSaudi Arabia IVD market rose to $605M in 2022: KaloramaThe market was driven in part by COVID-19 testing, with about 44 million PCR COVID-19 tests performed through last August.June 19, 2023Business InsightsIndia IVD market sales rose to $1.4B in 2022: Kalorama InformationAccording to Kalorama's forecasts, India’s IVD market will increase at a compound annual growth rate (CAGR) of 2.4% from 2022 to 2027.April 26, 2023Business InsightsMexico IVD sales reach $794M: Kalorama InformationImmunoassays are Mexico’s leading IVD segment, followed by point-of-care and microbiology/molecular. Other POC, other molecular, and flow cytometry will be key segments to watch in coming years.April 11, 2023Business InsightsChina worth watching in $3.95B world market for molecular POC tests: Kalorama InformationCentral and provincial governments have played a significant role in the expansion of the POC testing market in China.February 22, 2023Emergency Use AuthorizationCOVID-19 tests attempt to prove at-home testing concept can workThese COVID-19 tests were granted separate emergency use authorizations (EUAs) from the U.S. Food and Drug Administration (FDA) earlier in 2021 and all require nasal swab specimens from patients.August 22, 2021Page 1 of 1Top StoriesValidationImmunovia announces positive results for next-gen pancreatic cancer testDiagnostics company Immunovia announced positive results for the newest generation of its pancreatic cancer test from a model-development study, announcing that the test achieved both its primary and secondary endpoints.CollaborationVertex to pay $25M upfront to scale cell manufacturing technologyFinancial ResultsBristol Myers Squibb to reduce workforce in restructuring planLawsuitU.K. Patents Court rules Bio-Techne patents invalid in infringement lawsuitSponsor ContentVisit our Molecular Diagnostics Community